Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Preliminary results from IMpact-RSV trial

July 17, 1997

Sequus and Sam Yang sign marketing agreement for Amphocil

July 16, 1997

Katayama's new cephems

July 16, 1997

Toyama claims antibacterial agents

July 16, 1997

New carbapenem ester prodrug claimed by Nippon Lederle

July 16, 1997

FDA approves antibacterial generic from Mylan

July 14, 1997

UCLA isolates new antimicrobial agents

July 14, 1997

In vitro activity of novel pneumocandin antifungal agent

July 11, 1997

Lupulon for the treatment of MRSA

July 10, 1997

Transcell and Merck & Co. collaborate on antibacterial research

July 9, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.